COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic
Background. Oncohematological patients are more predispose to SARS-CoV-2 infection than healthy individuals and patients with malignant neoplasms, and also they have a worse prognosis, which is because of immune system disorders, both due to the underlying disease and as a result of immunosuppressiv...
Saved in:
| Main Authors: | G. B. Kuchma, U. A. Yakubova, L. K. Kozlova, S. A. Lebedenko, F. R. Sayfutdinov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01) -
Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01) -
Transformation of Chronic Myeloid Leukemia to Acute Undifferentiated Leukemia: Case Report and Literature Review
by: Oussama Grari, et al.
Published: (2025-04-01) -
Cardiovascular and metabolic problems associated with application of second generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
by: O. Y. Vinogradova
Published: (2015-10-01) -
The Role of Bosutinib in Chronic Myeloid Leukemia: An Indian Perspective
by: Mohan Bajranglal Agarwal, et al.
Published: (2024-08-01)